UNSPSC 51182801: Dextrose/oxytocin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GU600. This VA Drug Class (GU600) classifies this compound as belonging to the group OXYTOCICS.

UNSPSC 51182801 Dextrose/oxytocin is a Commodity code, but the available recent state and local procurement activity does not match its nominal scope. The single recorded opportunity—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—solicits naloxone and drug deactivation systems, not dextrose or oxytocin products. The county is procuring 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors must include all shipping and delivery costs in their proposals, comply with drug-free workplace and E-Verify requirements, maintain workers' compensation and commercial general liability insurance, and accept a three-month probationary termination period. The contract carries a two-year initial term with a one-year renewal option and is potentially FEMA-funded, triggering federal environmental compliance obligations. The mismatch between the code's stated category and the actual solicitation signals that this code shows little relevant recent activity for dextrose or oxytocin procurement at the state and local level.

The geographic and issuing-body data are too limited to characterize meaningful patterns. Seminole County, a Florida county government, is the only recent buyer recorded under this code. The response deadline for the naloxone and drug deactivation systems procurement was July 26, 2023, making this opportunity closed. No current open solicitations appear in the record.